Epidemiological, clinical, and virologic features of two family clusters of avian influenza A (H7N9) virus infections in Southeast China

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Xie, Jianfeng ^a,b   Weng, Yuwei ^a,b   Ou, Jianming ^a,b   Zhao, Lin ^a   Zhang, Yanhua ^a   Wang, Jinzhang ^a   Chen, Wei ^a   Huang, Meng ^a   Xiu, Wenqiong ^a   Chen, Hongbin ^a   Zhang, Yongjun ^a   Wu, Binshan ^a   He, Wenxiang ^a   Zhu, Ying ^a   You, Libin ^a   Huang, Zhimiao ^a   Zhang, Canming ^a   Hong, Longtao ^a,b   Wang, Wei ^b,c   Zheng, Kuicheng ^a,b  

^a Fujian Provincial Center for Disease Control and Prevention   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMINO ACID SUBSTITUTION; ANIMAL; AVIAN INFLUENZA; BIRD; CHINA; FAMILY; FEMALE; GENETICS; HUMAN; INFLUENZA; INFLUENZA A VIRUS (H7N9); ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PHYLOGENY; VIROLOGY; VIRUS GENOME;

AGED; AMINO ACID SUBSTITUTION; ANIMALS; BIRDS; CHINA; FAMILY; FEMALE; GENOME, VIRAL; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PHYLOGENY;

EID: 85018436130     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-01761-w     Document Type: Article

References (51)

1. Gao, H. N. et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 368, 2277-2285, doi:10.1056/NEJMoa1305584 (2013).
2. Qi, X. P. et al. Calculating the burden of disease of avian-origin H7N9 infections in China. BMJ Open 4, e004189, doi:10.1136/bmjopen-2013-004189 (2014).
3. Root, J. J. et al. Experimental infection of peridomestic mammals with emergent H7N9 (A/Anhui/1/2013) influenza A virus: Implications for biosecurity and wet markets. Virology 487, 242-248, doi:10.1016/j.virol.2015.10.020 (2016).
4. WHO. Monthly Risk Assessment Summary: Influenza at the Human-Animal Interface. http://www.who.int/influenza/human-animal-interface/HAI-Risk-Assessment/en/ (Accessed 2016 July 19).
5. Skowronski, D. M. et al. Avian influenza A (H7N9) virus infection in 2 travelers returning from China to Canada, January 2015. Emerg Infect Dis 22, 71-74, doi:10.3201/eid2201.151330 (2016).
6. Leung, Y. H. et al. Epidemiology of human influenza A (H7N9) infection in Hong Kong. J Microbiol Immunol Infect In press, doi: 10.1016/j.jmii.2015.06.004 (2015).
7. William, T. et al. Avian influenza (H7N9) virus infection in Chinese tourist in Malaysia. Emerg Infect Dis 21, 142-145, doi:10.3201/eid2101.141092 (2015).
8. Chen, G. W. et al. Genomic signatures for avian H7N9 viruses adapting to humans. PLoS One 11, e0148432, doi:10.1371/journal. pone.0148432 (2016).
9. Wu, P. et al. Human infection with influenza a(h7n9) virus during 3 major epidemic waves, china, 2013-2015. Emerg Infect Dis 22, 964-972, doi:10.3201/eid2206.151752 (2016).
10. Qin, Y. et al. Differences in the epidemiology of human cases of avian influenza A (H7N9) and A (H5N1) viruses infection. Clin Infect Dis 61, 563-571, doi:10.1093/cid/civ345 (2015).
11. Li, Q. et al. Epidemiology of human infections with avian influenza A (H7N9) virus in China. N Engl J Med 370, 520-531, doi:10.1056/NEJMoa1304617 (2014).
12. Xu, W. et al. Serological investigation of subclinical influenza A(H7H9) infection among healthcare and non-healthcare workers in Zhejiang Province, China. Clin Infect Dis 57, 919-921, doi:10.1093/cid/cit396 (2013).
13. Hu, J. et al. Limited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013. Euro Surveill 19, 20838, doi:10.2807/1560-7917.ES2014.19.25.20838 (2014).
14. Qi, X. et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ 347, f4752-f4752, doi:10.1136/bmj.f4752 (2013).
15. Yamayoshi, S. et al. Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts. Sci Rep 5, 8039, doi:10.1038/srep08039 (2015).
16. Shi, Y. et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 342, 243-247, doi:10.1126/science.1242917 (2013).
17. Zhou, J. et al. Biological features of novel avian influenza A (H7N9) virus. Nature 499, 500-503, doi:10.1038/nature12379 (2013).
18. Song, M. S. et al. Unique determinants of neuraminidase inhibitor resistance among N3, N7, and N9 avian influenza viruses. J Virol 89, 10891-10900, doi:10.1128/JVI.01514-15 (2015).
19. Colman, P. M. et al. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303, 41-44, doi:10.1038/303041a0 (1983).
20. Marjuki, H. et al. Characterization of drug-resistant influenza A (H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J Infect Dis 211, 249-257, doi:10.1093/infdis/jiu447 (2015).
21. Zhu, W. et al. Dual E627K and D701N mutations in the PB2 protein of A (H7N9) influenza virus increased its virulence in mammalian models. Sci Rep 5, 14170, doi:10.1038/srep14170 (2015).
22. Herfst, S. et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336, 1534-1541, doi:10.1126/science.1213362 (2012).
23. Fan, S. et al. Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology 384, 28-32, doi:10.1016/j.virol.2008.11.044 (2009).
24. Jiao, P. et al. A single amino acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 82, 1146-1154, doi:10.1128/JVI.01698-07 (2008).
25. Li, H. & Cao, B. Pandemic and avian influenza A viruses in humans: epidemiology, virology, clinical characteristics, and treatment strategy. Clin Chest Med 38, 59-70, doi:10.1016/j.ccm.2016.11.005 (2017).
26. Ding, H. et al. A family cluster of three confirmed cases infected with avian influenza A (H7N9) virus in Zhejiang Province of China. BMC Infect Dis 14, 698, doi:10.1186/s12879-014-0698-6 (2014).
27. Liu, T. et al. One family cluster of avian influenza A(H7N9) virus infection in Shandong, China. BMC Infect Dis 14, 98, doi:10.1186/1471-2334-14-98 (2014).
28. Yu, H. et al. The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet 367, 84, doi:10.1016/S0140-6736(05)67894-4 (2006).
29. Yu, H. J. et al. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet 383, 541-548, doi:10.1016/S0140-6736(13)61904-2 (2014).
30. Chen, C. et al. Multiple gene mutations identified in patients infected with influenza A (H7N9) virus. Sci Rep 6, 25614, doi:10.1038/srep25614 (2016).
31. Husain, M. Avian influenza A (H7N9) virus infection in humans: epidemiology, evolution, and pathogenesis. Infect Genet Evol 28, 304-312, doi:10.1016/j.meegid.2014.10.016 (2014).
32. Kim, K., Omori, R., Ueno, K., Iida, S. & Ito, K. Host-specific and segment-specific evolutionary dynamics of avian and human influenza A viruses: a systematic review. PLoS One 11, e0147021, doi:10.1371/journal.pone.0147021 (2016).
33. Yamayoshi, S. et al. Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts. Sci Rep 5, 8039, doi:10.1038/srep08039 (2015).
34. Yamayoshi, S. et al. Virulence-affecting amino acid changes in the PA protein of H7N9 influenza A viruses. J Virol 88, 3127-3134, doi:10.1128/JVI.03155-13 (2014).
35. Zhu, W. et al. Dual E627K and D701N mutations in the PB2 protein of A(H7N9) influenza virus increased its virulence in mammalian models. Sci Rep 5, 14170, doi:10.1038/srep14170 (2015).
36. Wang, D. et al. A returning migrant worker with avian influenza A (H7N9) virus infection in Guizhou, China: a case report. J Med Case Rep 9, 109, doi:10.1186/s13256-015-0580-1 (2015).
37. Wang, Y. et al. Towards a better understanding of the novel avian-origin H7N9 influenza A virus in China. Sci Rep 3, 2318, doi:10.1038/srep02318 (2013).
38. Hai, R. et al. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun 4, 2854, doi:10.1038/ncomms3854 (2013).
39. Durrant, M. G., Eggett, D. L. & Busath, D. D. Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence. BMC Genet 16, S3, doi:10.1186/1471-2156-16-S2-S3 (2015).
40. Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368, 1888-1897, doi:10.1056/NEJMoa1304459 (2013).
41. Zhang, W. et al. Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza A viruses by a D225G substitution. J Virol 87, 5949-5958, doi:10.1128/JVI.00545-13 (2013).
42. Martin, J. et al. Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology 241, 101-111, doi:10.1006/viro.1997.8958 (1998).
43. Tambunan, U. S. & Ramdhan. Identification of sequence mutations affecting hemagglutinin specificity to sialic acid receptor in influenza A virus subtypes. Bioinformation 5, 244-249 (2010).
44. Wang, J. et al. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc Natl Acad Sci USA 110, 1315-1320, doi:10.1073/pnas.1216526110 (2013).
45. Belser, J. A. et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501, 556-559, doi:10.1038/nature12391 (2013).
46. Xu, L. et al. Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets. J Infect Dis 209, 551-556, doi:10.1093/infdis/jit474 (2014).
47. Xiang, N. et al. Use of national pneumonia surveillance to describe influenza A (H7N9) virus epidemiology, China, 2004-2013. Emerg Infect Dis 19, 1784-1790, doi:10.3201/eid1911.130865 (2013).
48. National Health and Family Planning Commission, People's Republic of China Guidelines of case clinical intervention and disease control and prevention of human infection with avian influenza H7N9 virus. Available at: http://www.moh.gov.cn/mohwsyjbgs/fkzs/list.shtml (Accessed 2016 September 19).
49. National Health and Family Planning Commission of the People's Republic of China. Chinese guideline of diagnosis and treatment for human infections with the avian influenza A(H7N9) virus (2014 edition).
50. WHO. Real-time RT-PCR Protocol for the Detection of Avian Influenza A(H7N9) Virus. Available: http://www.who.int/influenza/gisrs-laboratory/cnic-realtime-rt-pcr-protocol-a-h7n9.pdf?ua=1 (Accessed 2014 May 10).
51. Xie, J. et al. Establishment of assay for amplifying and sequencing the complete genome of avian influenza virus A (H7N9). Chin J Zoon 31, 795-799, doi:10.3969/j.issn.1002-2694.2015.09.003 (2015).